Page last updated: 2024-09-04

sk&f 83959 and Cognitive Dysfunction

sk&f 83959 has been researched along with Cognitive Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banasikowski, TJ; Fan, T; George, SR; Grace, AA; Perreault, ML	1

Other Studies

1 other study(ies) available for sk&f 83959 and Cognitive Dysfunction

Article	Year
The atypical dopamine receptor agonist SKF 83959 enhances hippocampal and prefrontal cortical neuronal network activity in a rat model of cognitive dysfunction. The European journal of neuroscience, 2017, Volume: 46, Issue:4 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cognitive Dysfunction; Disease Models, Animal; Dopamine Agonists; Hippocampus; Male; Maze Learning; Nerve Net; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine	2017

Article

Year

The atypical dopamine receptor agonist SKF 83959 enhances hippocampal and prefrontal cortical neuronal network activity in a rat model of cognitive dysfunction.

The European journal of neuroscience, 2017, Volume: 46, Issue:4

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cognitive Dysfunction; Disease Models, Animal; Dopamine Agonists; Hippocampus; Male; Maze Learning; Nerve Net; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine

2017